Abstract:Objective To investigate the effect of continuous veno-venous hemofiltration(CVVH) in the treatment of acute severe hyponatremia. Methods Six patients with acute severe hyponatremia were studied, including 5 males and 1 female, aged 48.5(25-61) years. Clinical manifestations of hyponatremia included confusion (6/6), drowsiness(3/6), and delirium (3/6). The course of hyponatremia before the initiation of CVVH was 45-48 hours. AN69, AV600, FH66 and HF1200 hemofilters were applied and changed every 24 hours. The ultrafiltration rate was 2 000 ml/h, with a blood flow rate of 200-250 ml/min, and the substitute fluid was infused by a pre-dilution route. Low molecular weight heparin was used for anticoagulation. Results The average treatment duration of CVVH was 59.7(45.6-86) hours. All the patients survived and tolerated CVVH well. During CVVH, the serum sodium increased significantly from (101.2±4.2)mmol/L before CVVH, to (115.0±2.7)mmol/L at the 6th hour of CVVH, (129.2±4.1)mmol/L at the 24th hour, and (140.3±1.6)mmol/L at the 48th hour of CVVH; with the correction rate of serum sodium controlled at (2.5±0.4)mmol·L -1·h -1 over the first 24 hours,(1.2±0.1)mmol·L -1·h -1 for the first 48th hour, and the correction rate of (0.82±0.10)mmol·L -1·h -1. The sodium concentrations in the replacement solution were (16.0±6.0)mmol/L higher than the serum sodium concentration at 0 hour, (11.6±4.3)mmol/L higher at 4th hour, (5.5±5.1)mmol/L higher at 24th hour, and (0.75±0.96)mmol/L higher at 48th hour of CVVH. After CVVH, the serum osmolarity increased significantly, from (216.7±7.4)mOsm/kgH 2O pre-CVVH, to (245.0±5.5)mOsm/kgH 2O at 6th hour, with a correction rate of (5.16±0.81) mOsm·kgH 2O -1·h -1; (272.7±7.1)mOsm/kgH 2O at 24th hour, with a correction rate of (2.33±0.28) mOsm·kgH 2O -1·h -1; and (295.0±4.2)mOsm/kgH 2O at 48th hour, with a correction rate of (1.63±0.20) mOsm·kgH 2O -1·h -1.The Glasgow scores and APACHEⅡ scores improved significantly as compared to pretreatment. Conclusion CVVH is effective in the treatment of acute severe hyponatremia, and could be considered as a treatment option because of its slow and continuous nature. A low-sodium replacement solution should be prepared to minimize its sodium concentration difference from the serum concentration. We recommend that the serum sodium concentration be corrected at an average rate of (2.50±0.14) mmol·L -1·h -1 at 6h, (1.2±0.1)mmol·L -1·h -1 at 24h and (0.82±0.10) mmol·L -1·h -1 at 48h.

Clearance of myoglobin by high cutoff continuous veno-venous hemodialysis in a patient with rhabdomyolysis: a case report

Clearance of NT-proBNP and Procalcitonin during Continuous Venovenous Hemodialysis with the Medium Cutoff Filter in Patients with Rhabdomyolysis-Associated Early Acute Kidney Injury

Blood purification with a cytokine adsorber for the elimination of myoglobin in critically ill patients with severe rhabdomyolysis

High Cutoff Hemodialysis for Treatment of Patient with Multiple Myeloma:A Case Report

Successful Reduction of Creatine Kinase and Myoglobin Levels in Severe Rhabdomyolysis Using Extracorporeal Blood Purification (CytoSorb®)

Endotoxemia after high cutoff hemodialysis for treatment of patient with multiple myeloma can be prevented by using ultrapure dialysate: a case report

High cut-off membrane for in-vivo dialysis of free plasma hemoglobin in a patient with massive hemolysis

Protein Loss in Critically Ill Patients During Continuous Veno-Venous Hemofiltration

Application of Continuous Veno-Venous Hemodiafiltration to Severely Acute Renal Failure after Cardiac Surgery

High-Volume Hemodiafiltration with Step-Down Approach versus Standard-of-Care Continuous Renal Replacement Therapy Approach in Critically Ill Burn Patients

Middle molecule clearance with high cut-off dialyzer versus high-flux dialyzer using continuous veno-venous hemodialysis with regional citrate anticoagulation: A prospective randomized controlled trial

High-cutoff hemodialysis in multiple myeloma patients with acute kidney injury

Comparison of the removal of uraemic toxins with medium cut-off and high-flux dialysers: a randomized clinical trial

Dengue rhabdomyolysis successfully treated with hemoperfusion using CytoSorb® in combination with continuous renal replacement therapy: a case report

Hemoadsorption therapy for myoglobin removal in rhabdomyolysis: consensus of the hemoadsorption in rhabdomyolysis task force

Clinical effects of continuous veno-venous hemofiltration combined with hemoperfusion for the treatment of multiple myeloma complicated with acute kidney injury

The effect of continuous renal replacement therapy in patients with acute kidney injury on the serum levels of urea,creatinine and cystatin C

[Diagnosis and treatment of 23 cases with rhabdomyolysis related acute renal failure]

Lactate clearance and metabolic aspects of continuous high-volume hemofiltration

Continuous Veno-Venous Hemofiltration in Treatment of Acute Severe Hyponatremia:A Report of 6 Cases

Metabolism of albumin after continuous venovenous hemofiltration in patients with systemic inflammatory response syndrome.